03.02.2017 Views

Pharmacists in Smoking Cessation

IPU-Review-FEBRUARY-2017

IPU-Review-FEBRUARY-2017

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

CPD overview<br />

Self-appraisal<br />

What do I know about ankylos<strong>in</strong>g spondylitis<br />

and how it is diagnosed?<br />

Am I familiar with the features of <strong>in</strong>flammatory<br />

back pa<strong>in</strong>?<br />

Am I familiar with the available treatment options?<br />

Can I counsel patients and their carers effectively<br />

on their AS drug therapy?<br />

Can I provide appropriate self-care advice to a<br />

patient with AS?<br />

Personal Plan<br />

Includ<strong>in</strong>g a list of desired learn<strong>in</strong>g outcomes <strong>in</strong> a personal<br />

learn<strong>in</strong>g plan is a helpful self-analytical tool.<br />

Create a list of desired learn<strong>in</strong>g outcomes.<br />

How will I accomplish these learn<strong>in</strong>g outcomes?<br />

Identify resources available to achieve learn<strong>in</strong>g<br />

outcomes.<br />

Develop a realistic timeframe for the plan.<br />

pharmacy to ensure that you have appropriate<br />

guidel<strong>in</strong>es <strong>in</strong> place to ensure they are offered<br />

appropriate advice and counsell<strong>in</strong>g.<br />

Evaluate professional resource materials available<br />

<strong>in</strong> the pharmacy and source additional material if<br />

necessary.<br />

Evaluate availability of patient support materials<br />

and source additional material if necessary.<br />

Evaluate<br />

Consider outcomes of learn<strong>in</strong>g and impact of learn<strong>in</strong>g.<br />

Have I met my desired learn<strong>in</strong>g outcomes?<br />

Do I now feel confident to be able to dist<strong>in</strong>guish<br />

between mechanical back pa<strong>in</strong> and <strong>in</strong>flammatory<br />

back pa<strong>in</strong>?<br />

Do I now feel confident to engage with and counsel<br />

patients with AS?<br />

Am I and my team now able to fully support<br />

patients with AS?<br />

Have further learn<strong>in</strong>g needs been identified?<br />

Action<br />

Activities chosen should be outcomes based to meet<br />

learn<strong>in</strong>g objectives.<br />

Implement plan.<br />

Read this article on AS.<br />

Review how you manage AS patients <strong>in</strong> your<br />

n Ensure patients on<br />

DMARDs and biologics are<br />

gett<strong>in</strong>g regular blood tests<br />

and that they know they<br />

should stop or reduce their<br />

dose <strong>in</strong> the case of adverse<br />

events <strong>in</strong>clud<strong>in</strong>g <strong>in</strong>fection.<br />

n Each year, offer flu<br />

vacc<strong>in</strong>ation to all<br />

patients on DMARDs and<br />

biologics. Also encourage<br />

other vacc<strong>in</strong>ations,<br />

e.g. Pneumococcal and<br />

Hepatitis B.<br />

n For patients on biologics,<br />

recommend periodic sk<strong>in</strong><br />

analysis because of risk<br />

of sk<strong>in</strong> cancers. Advise<br />

on use of sun screen and<br />

avoid<strong>in</strong>g the sun – see Irish<br />

Cancer Society website for<br />

guidel<strong>in</strong>es.<br />

AVAILABLE ONLINE<br />

AND IN-STORE!<br />

n Advise patients on biologics<br />

to avoid live vacc<strong>in</strong>es, e.g.<br />

yellow fever.<br />

Document your learn<strong>in</strong>g<br />

Create a record <strong>in</strong> my ePortfolio.<br />

Complete the true or false questions at the end of<br />

this article.<br />

As part of this record, complete an evaluation, not<strong>in</strong>g<br />

whether learn<strong>in</strong>g outcomes were achieved and<br />

identify<strong>in</strong>g any future learn<strong>in</strong>g needs.<br />

Your 5-m<strong>in</strong>ute<br />

assessment<br />

n Encourage patients to carry<br />

their patient alert card<br />

Digestive<br />

with them.<br />

and Imm<br />

Answer the follow<strong>in</strong>g five questions<br />

true or false:<br />

Signpost<strong>in</strong>g<br />

1. Women are more likely to develop ankylos<strong>in</strong>g spondylitis.<br />

The Ankylos<strong>in</strong>g Spondylitis<br />

Association of Ireland<br />

and Arthritis Ireland<br />

provide <strong>in</strong>formation and<br />

support to patients and<br />

2. When sitt<strong>in</strong>g, patients should move their sp<strong>in</strong>e regularly<br />

Support<br />

(e.g. by stretch<strong>in</strong>g<br />

for<br />

their back and pull<strong>in</strong>g<br />

Life<br />

their shoulders back).<br />

3. Patients with AS test positive rheumatoid factor.<br />

healthcare professionals.<br />

4. Anti-TNF therapy should not be started without screen<strong>in</strong>g<br />

SUAS (Support<strong>in</strong>g and<br />

for TB first.<br />

Understand<strong>in</strong>g Ankylos<strong>in</strong>g<br />

Spondylitis) is a booklet that<br />

can be downloaded from<br />

www.ankylos<strong>in</strong>g-spondylitis.ie.<br />

5. AS patients have an <strong>in</strong>creased risk of osteoporosis.<br />

Answers:<br />

1. False. 2. True. 3. False. 4. True. 5. True.<br />

40<br />

IPUREVIEW FEBRUARY 2017

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!